| Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy M Sohn, K Kim, MJ Uddin, G Lee, I Hwang, H Kang, H Kim, JH Lee, H Ha American Journal of Physiology-Renal Physiology 312 (2), F323-F334, 2017 | 69 | 2017 |
| Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011–2013 S Jeong, M Sohn, JH Kim, M Ko, H Seo, YK Song, B Choi, N Han, HS Na, ... Trials 18, 1-8, 2017 | 45 | 2017 |
| How to cope with emerging viral diseases: Lessons from South Korea's strategy for COVID-19, and collateral damage to cardiometabolic health S Lim, M Sohn The Lancet Regional Health–Western Pacific 30, 2023 | 33 | 2023 |
| Impact of COVID-19 and associated preventive measures on cardiometabolic risk factors in South Korea M Sohn, BK Koo, HI Yoon, KH Song, ES Kim, HB Kim, S Lim Journal of obesity & metabolic syndrome 30 (3), 248, 2021 | 31 | 2021 |
| Efficacy and Safety of Lactobacillus plantarum K50 on Lipids in Koreans With Obesity: A Randomized, Double-Blind Controlled Clinical Trial M Sohn, GY Na, J Chu, H Joung, BK Kim, S Lim Frontiers in endocrinology 12, 790046, 2022 | 25 | 2022 |
| Effectiveness of clinical pharmacist service on drug-related problems and patient outcomes for hospitalized patients with chronic kidney disease: a randomized controlled trial YK Song, S Jeong, N Han, H Na, HY Jang, M Sohn, YS Kim, KW Joo, ... Journal of Clinical Medicine 10 (8), 1788, 2021 | 21 | 2021 |
| Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial M Sohn, H Jung, WS Lee, TH Kim, S Lim Diabetes & Metabolism Journal, 2022 | 17 | 2022 |
| Correlation of dynamic membrane fluctuations in red blood cells with diabetes mellitus and cardiovascular risks M Sohn, JE Lee, MG Ahn, YK Park, S Lim Scientific reports 11 (1), 7007, 2021 | 15 | 2021 |
| Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients M Sohn, MG Kim, N Han, IW Kim, J Gim, SI Min, EY Song, YS Kim, ... Scientific Reports 8 (1), 18064, 2018 | 15 | 2018 |
| Pharmacogenomic biomarker information in FDA‐approved paediatric drug labels T Kim, N Han, M Sohn, JM Oh, EK Lee, E Ji, IW Kim Basic & Clinical Pharmacology & Toxicology 116 (5), 438-444, 2015 | 11 | 2015 |
| Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease CH Kwak, M Sohn, N Han, YS Cho, YS Kim, JM Oh International Journal of Clinical Pharmacology and Therapeutics 56 (7), 321, 2018 | 8 | 2018 |
| Cardiovascular efficacy and safety of antidiabetic agents: A network meta‐analysis of randomized controlled trials M Sohn, JP Frias, S Lim Diabetes, Obesity and Metabolism 25 (12), 3560-3577, 2023 | 7 | 2023 |
| Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis … M Sohn, JW Dietrich, MA Nauck, S Lim Cardiovascular Diabetology 22 (1), 153, 2023 | 6 | 2023 |
| Effects of initial combinations of gemigliptin plus metformin compared with glimepiride plus metformin on gut microbiota and glucose regulation in obese patients with type 2 … S Lim, M Sohn, JC Florez, MA Nauck, J Ahn Nutrients 15 (1), 248, 2023 | 6 | 2023 |
| Vascular and metabolic effects of ipragliflozin versus sitagliptin (IVS) in type 2 diabetes treated with sulphonylurea and metformin: IVS study SM Kang, HM Yun, M Sohn, S Lim Diabetes, Obesity and Metabolism 25 (7), 1922-1931, 2023 | 5 | 2023 |
| Breath analyzer for personalized monitoring of exercise-induced metabolic fat burning DV Del Orbe, HJ Park, MJ Kwack, HK Lee, JG Lim, I Park, M Sohn, S Lim, ... Sensors and Actuators B: Chemical 369, 132192, 2022 | 5 | 2022 |
| Effects of tumor necrosis factor-alpha inhibitors on the incidence of tuberculosis HJ Park, BY Choi, M Sohn, NY Han, IW Kim, JM Oh Korean Journal of Clinical Pharmacy 28 (4), 333-341, 2018 | 4 | 2018 |
| Survey of Life and Dietary Styles on Patients with Gastroesophageal Reflux Disease HS Kim, M Sohn, UD Sohn Korean Journal of Clinical Pharmacy 24 (4), 248-254, 2014 | 4 | 2014 |
| Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long‐term follow‐up of the ESCAPE study M Sohn, EJ Chun, S Lim Journal of Diabetes 14 (8), 524-531, 2022 | 3 | 2022 |
| Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects. S Lim, M Sohn, Y Shin, E Ferrannini Diabetes, Obesity & Metabolism 24 (4), 2022 | 3 | 2022 |
